P090024/S013: Atellica IM Hepatitis B e Antigen (HBeAg)
FDA’s recorded scope: Approval for the Atellica CI Analyzer with Atellica Sample Handler configuration for Atellica IM HBcT2, aHBs2, HBeAg, aHBcM, aHBe2, HBsII & HBsII Conf assays.
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 3 FDA records to the applicant name Siemens Healthcare Diagnostics. 2 entries are PMA supplements. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jul 16, 2025 to Oct 17, 2025. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code LOM appears in 2 of the 3 linked filings. The collection spans 2 FDA product codes and 3 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P030040, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 511 Benedict Ave., Tarrytown, NY, 10591. Recorded on P090024/S013, decision dated Oct 17, 2025.
Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen); Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions.
FDA’s recorded scope: Approval for the Atellica CI Analyzer with Atellica Sample Handler configuration for Atellica IM HBcT2, aHBs2, HBeAg, aHBcM, aHBe2, HBsII & HBsII Conf assays.
FDA’s recorded scope: Approval for the Atellica CI Analyzer with Atellica Sample Handler configuration for Atellica IM HBcT2, aHBs2, HBeAg, aHBcM, aHBe2, HBsII & HBsII Conf assays.
FDA’s recorded scope: Approval for the implementation of a particle size analyzer utilized for the in-process testing of paramagnetic particles.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.